ENPP2 and breast cancer: Moreover, targeting ATX in a syngeneic orthotopic mouse model of BC decreased CCL11, IL-9, IL-12p40, M-CSF, and IFN-γ, which reversed pro-survival signals and radio-resistance in cancer cells.